Neuropsychiatric Disease and Treatment
Dove Medical Press Ltd. · New Zealand
Metrics
- Impact factor
- 3.2+0.3 Clarivate JCR
- WoS quartile
- Q2 Clarivate JCR, best category
- SJR
- 0.947Q2 SCImago
- h-index
- 55
- CAS tier
- Tier 3 Chinese Academy of Sciences
- Citations per paper
- 3.1 last 2 years
- Articles per year
- 322
- Self-citation
- 4%
- Fee (APC), est.
- $3,234 estimated, check the journal
About this journal
- ISSN
- 1176-6328 (print) · 1178-2021 (online)
- Publisher
- Dove Medical Press Ltd.
- Country
- New Zealand · Western Europe
- Indexed in
- SCIE
- Access
- Hybrid · 98.9% gold OA
- Founded
- 2005
- Original research
- 83.3%
- Subject areas
- Medicine, Neuroscience
- Categories
- Clinical Neurology, Psychiatry
- Common topics
- Medicine, Psychology, Psychiatry, Biology, Internal medicine
Similar journals
- Q2WoS
Journal of Physical Chemistry B
Impact factor 3.2h-index 363SJR 0.79 - Q2WoS
Journal of Cell Biology
Impact factor 6.1h-index 353SJR 3.27 - Q2WoS
Journal of Immunology
Impact factor 4h-index 345SJR 1.44 - Q2WoS
Langmuir
Impact factor 4.4h-index 300SJR 0.76 - Q2WoS
Human Molecular Genetics
Impact factor 3.1h-index 255SJR 1.45 - Q2WoS
Journal of Nutrition
Impact factor 4.2h-index 240SJR 1.21
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals